Christoph Lengauer, Chief Scientific Officer at Blueprint Medicines Corp (BPMC), sold 84,998 shares at $20.98 ($1.8M) on 2015-11-03, disclosed to the SEC on 2015-11-04.
Scheduled sale ($1.8M) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.10 | 48,264 | $1.0M | 56.9% |
| 2 | $20.98 | 36,734 | $771K | 43.1% |
| Total | $21.05 avg | 84,998 | $1.8M | 100% |
| Filing → |
| BPMC | SELL | 2015-12-17 | $780K | — | Filing → |